Financhill
Back

Reata Pharmaceuticals Quote, Financials, Valuation and Earnings

Reata Pharmaceuticals Price Quote

$42.84
+1.98 (+4.85%)
(Updated: January 27, 2023 at 12:30 PM ET)

Reata Pharmaceuticals Key Stats

Buy
72
Reata Pharmaceuticals (RETA) is a Buy

Day range:
$38.97 - $42.49
52-week range:
$18.47 - $46.90
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
473.22
P/B ratio:
331.71%

Volume:
1M
Avg. volume:
556.4K
1-year change:
54.6%
Market cap:
$1.5B
Revenue:
$11.5M
EPS:
$-8.56

How Much Does Reata Pharmaceuticals Make?

Is Reata Pharmaceuticals Growing As A Company?

  • What Is Reata Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.93%
  • What Is Reata Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Reata Pharmaceuticals Stock Price Performance

What Is Reata Pharmaceuticals 52-Week High & Low?

Reata Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Reata Pharmaceuticals?

Is Reata Pharmaceuticals Cash Flow Positive?

  • What Is RETA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$276.8M
  • What Is Reata Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.3M
  • What Is Reata Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$405.9M

Reata Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    RETA return on invested capital is -242.48%
  • What Is Reata Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -46.37%
  • What Is RETA Return On Equity?
    ROE is a measure of profitability and is -242.48%

Reata Pharmaceuticals Earnings Date & Stock Price

Reata Pharmaceuticals Competitors

Reata Pharmaceuticals Dividend Yield

Data Unavailable

Reata Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 28.18%
Revenue: -92.69% -36.71%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 62.40
Upside from Last Price: 52.72%

Major Shareholders

  • How many RETA shares are owned by institutional investors?
    39.7M RETA shares are owned by institutional investors
  • How many RETA shares are owned by insiders?
    413K RETA shares are owned by insiders